The Benefit of Minocycline on Negative Symptoms in Schizophrenia: Extent and Mechanisms

NCT02928965 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

207

Enrollment

OTHER

Sponsor class

Conditions

Schizophrenia and Disorders With Psychotic Features

Interventions

DRUG: Minocycline
DRUG: Placebo

Sponsor

University of Manchester

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]